BioCentury
ARTICLE | Company News

PanCel, Geron licensing deal

March 6, 2003 8:00 AM UTC

Geron (GERN) granted a non-exclusive license for its human telomerase reverse transcriptase (hTERT) technology to cellular therapy company PanCel (Del Mar, Calif.). PanCel will use the technology to d...